Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immuno... Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.037 | 4.16666666667 | 0.888 | 0.9799 | 0.810001 | 498351 | 0.90472952 | CS |
| 4 | 0.235 | 34.0579710145 | 0.69 | 1.7 | 0.6315 | 11428756 | 1.39956009 | CS |
| 12 | -0.085 | -8.41584158416 | 1.01 | 1.7 | 0.63 | 4494960 | 1.36369184 | CS |
| 26 | 0.1178 | 14.5936570862 | 0.8072 | 1.7 | 0.63 | 2108236 | 1.34422878 | CS |
| 52 | 0.035 | 3.93258426966 | 0.89 | 1.93 | 0.58 | 1410005 | 1.3048 | CS |
| 156 | -7.655 | -89.2191142191 | 8.58 | 9.59 | 0.49 | 514349 | 1.38547581 | CS |
| 260 | -14.075 | -93.8333333333 | 15 | 27.95 | 0.49 | 470555 | 1.73905063 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
